These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 12460895)
1. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Campbell RB; Fukumura D; Brown EB; Mazzola LM; Izumi Y; Jain RK; Torchilin VP; Munn LL Cancer Res; 2002 Dec; 62(23):6831-6. PubMed ID: 12460895 [TBL] [Abstract][Full Text] [Related]
2. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Krasnici S; Werner A; Eichhorn ME; Schmitt-Sody M; Pahernik SA; Sauer B; Schulze B; Teifel M; Michaelis U; Naujoks K; Dellian M Int J Cancer; 2003 Jul; 105(4):561-7. PubMed ID: 12712451 [TBL] [Abstract][Full Text] [Related]
3. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Yuan F; Leunig M; Huang SK; Berk DA; Papahadjopoulos D; Jain RK Cancer Res; 1994 Jul; 54(13):3352-6. PubMed ID: 8012948 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of angiogenesis-targeted peptide and hydrophobized polyethylene glycol conjugate. Maeda N; Takeuchi Y; Takada M; Namba Y; Oku N Bioorg Med Chem Lett; 2004 Feb; 14(4):1015-7. PubMed ID: 15013013 [TBL] [Abstract][Full Text] [Related]
5. Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatin. Abu Lila AS; Matsumoto H; Doi Y; Nakamura H; Ishida T; Kiwada H Eur J Pharm Biopharm; 2012 Aug; 81(3):524-31. PubMed ID: 22554766 [TBL] [Abstract][Full Text] [Related]
6. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity. Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094 [TBL] [Abstract][Full Text] [Related]
7. [Construction and evaluation of non-specific targeting cationic polymer lipid liposomes]. Chen T; Wang RT; Wang Z; Lu TL; Zhao W Yao Xue Xue Bao; 2010 Mar; 45(3):359-64. PubMed ID: 21351513 [TBL] [Abstract][Full Text] [Related]
8. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model. Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471 [TBL] [Abstract][Full Text] [Related]
9. Characterization of cationic liposome formulations designed to exhibit extended plasma residence times and tumor vasculature targeting properties. Ho EA; Ramsay E; Ginj M; Anantha M; Bregman I; Sy J; Woo J; Osooly-Talesh M; Yapp DT; Bally MB J Pharm Sci; 2010 Jun; 99(6):2839-53. PubMed ID: 20091826 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomes. Zhao W; Zhuang S; Qi XR Int J Nanomedicine; 2011; 6():3087-98. PubMed ID: 22163162 [TBL] [Abstract][Full Text] [Related]
11. Impact of PEGylation on biodistribution and tumor accumulation of Lipid-Mu peptide-DNA. Bai J; Zhou Z; Tang H; Song S; Peng J; Xu Y J Liposome Res; 2013 Mar; 23(1):1-10. PubMed ID: 23077979 [TBL] [Abstract][Full Text] [Related]
12. PEG-coated irinotecan cationic liposomes improve the therapeutic efficacy of breast cancer in animals. Zhang L; Cao DY; Wang J; Xiang B; Dun JN; Fang Y; Xue GQ Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3347-61. PubMed ID: 24379067 [TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model. Abu Lila AS; Kizuki S; Doi Y; Suzuki T; Ishida T; Kiwada H J Control Release; 2009 Jul; 137(1):8-14. PubMed ID: 19285528 [TBL] [Abstract][Full Text] [Related]
14. Intra-tumor distribution of PEGylated liposome upon repeated injection: No possession by prior dose. Nakamura H; Abu Lila AS; Nishio M; Tanaka M; Ando H; Kiwada H; Ishida T J Control Release; 2015 Dec; 220(Pt A):406-413. PubMed ID: 26548975 [TBL] [Abstract][Full Text] [Related]
15. Development and characterization of magnetic cationic liposomes for targeting tumor microvasculature. Dandamudi S; Campbell RB Biochim Biophys Acta; 2007 Mar; 1768(3):427-38. PubMed ID: 17258172 [TBL] [Abstract][Full Text] [Related]
16. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. Li SD; Huang L Biochim Biophys Acta; 2009 Oct; 1788(10):2259-66. PubMed ID: 19595666 [TBL] [Abstract][Full Text] [Related]
18. Effects of surface charge of low molecular weight heparin-modified cationic liposomes on drug efficacy and toxicity. Li H; Chen Y; Deng Y; Wang Y; Ke X; Ci T Drug Dev Ind Pharm; 2017 Jul; 43(7):1163-1172. PubMed ID: 28277844 [TBL] [Abstract][Full Text] [Related]
19. Circulation kinetics and biodistribution of dual-labeled polymersomes with modulated surface charge in tumor-bearing mice: comparison with stealth liposomes. Lee JS; Ankone M; Pieters E; Schiffelers RM; Hennink WE; Feijen J J Control Release; 2011 Oct; 155(2):282-8. PubMed ID: 21820023 [TBL] [Abstract][Full Text] [Related]
20. Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor. Abu Lila AS; Doi Y; Nakamura K; Ishida T; Kiwada H J Control Release; 2010 Mar; 142(2):167-73. PubMed ID: 19861140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]